表观遗传修饰：糖尿病防治新靶点

doi:10.16138/j.1673-6087.2021.06.011

摘要/Abstract

关键词: 表观遗传, 糖尿病, 胰岛β细胞, DNA甲基化, 组蛋白修饰

中图分类号:

R587.1

韦晓, 孙烁烁, 陈国芳, 刘超. 表观遗传修饰：糖尿病防治新靶点[J]. 内科理论与实践, 2021, 16(06): 422-426.

图/表 1

参考文献 43

[1]	Ling C, Rönn T. Epigenetics in human obesity and type 2 diabetes[J]. Cell Metab, 2019, 29(5): 1028-1044. doi: 10.1016/j.cmet.2019.03.009 URL
[2]	Feinberg AP. The key role of epigenetics in human disease prevention and mitigation[J]. N Engl J Med, 2018, 378(14): 1323-1334. doi: 10.1056/NEJMra1402513 URL
[3]	Kato M, Natarajan R. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory[J]. Nat Rev Nephrol, 2019, 15(6): 327-345. doi: 10.1038/s41581-019-0135-6 URL
[4]	Rosen ED, Kaestner KH, Natarajan R, et al. Epigenetics and epigenomics: implications for diabetes and obesity[J]. Diabetes, 2018, 67(10): 1923-1931. doi: 10.2337/db18-0537 pmid: 30237160
[5]	Singh R, Chandel S, Dey D, et al. Epigenetic modification and therapeutic targets of diabetes mellitus[J]. Biosci Rep, 2020, 40(9): BSR20202160.
[6]	Greenberg MVC, Bourc'his D. The diverse roles of DNA methylation in mammalian development and disease[J]. Nat Rev Mol Cell Biol, 2019, 20(10): 590-607. doi: 10.1038/s41580-019-0159-6 URL
[7]	Johnson ND, Conneely KN. The role of DNA methylation and hydroxymethylation in immunosenescence[J]. Ageing Res Rev, 2019, 51: 11-23. doi: 10.1016/j.arr.2019.01.011 URL
[8]	Xu GL, Bochtler M. Reversal of nucleobase methylation by dioxygenases[J]. Nat Chem Biol, 2020, 16(11): 1160-1169. doi: 10.1038/s41589-020-00675-5 URL
[9]	Wahl S, Drong A, Lehne B, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity[J]. Nature, 2017, 541(7635): 81-86. doi: 10.1038/nature20784 URL
[10]	Chambers JC, Loh M, Lehne B, et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study[J]. Lancet Diabetes Endocrinol, 2015, 3(7): 526-534. doi: 10.1016/S2213-8587(15)00127-8 URL
[11]	Paul DS, Teschendorff AE, Dang MA, et al. Increased DNA methylation variability in type 1 diabetes across three immune effector cell types[J]. Nat Commun, 2016, 7: 13555. doi: 10.1038/ncomms13555 URL
[12]	Hjort L, Martino D, Grunnet LG, et al. Gestational diabetes and maternal obesity are associated with epigenome-wide methylation changes in children[J] JCI Insight, 2018, 3(17): e122572. doi: 10.1172/jci.insight.122572 URL
[13]	Stricker SH, Köferle A, Beck S. From profiles to function in epigenomics[J]. Nat Rev Genet, 2017, 18(1): 51-66. doi: 10.1038/nrg.2016.138 pmid: 27867193
[14]	Bates SE. Epigenetic therapies for cancer[J]. N Engl J Med, 2020, 383(7): 650-663. doi: 10.1056/NEJMra1805035 URL
[15]	Gao M, Deng XL, Liu ZH, et al. Liraglutide protects β-cell function by reversing histone modification of Pdx-1 proximal promoter in catch-up growth male rats[J]. J Diabetes Complications, 2018, 32(11): 985-994. doi: 10.1016/j.jdiacomp.2018.08.002 URL
[16]	Zhao L, Zhang F, Ding X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes[J]. Science, 2018, 359(6380): 1151-1156. doi: 10.1126/science.aao5774 URL
[17]	Zhong Q, Kowluru RA. Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon[J]. J Cell Biochem, 2010, 110(6): 1306-1313. doi: 10.1002/jcb.22644 pmid: 20564224
[18]	Hong S, Zhou W, Fang B, et al. Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion[J]. Nat Med, 2017, 23(2): 223-234. doi: 10.1038/nm.4245 URL
[19]	Asif S, Morrow NM, Mulvihill EE, et al. Understanding dietary intervention-mediated epigenetic modifications in metabolic diseases[J]. Front Genet, 2020, 11: 590369. doi: 10.3389/fgene.2020.590369 URL
[20]	Calderon D, Nguyen MLT, Mezger A, et al. Landscape of stimulation-responsive chromatin across diverse human immune cells[J]. Nat Genet, 2019, 51(10): 1494-1505. doi: 10.1038/s41588-019-0505-9 pmid: 31570894
[21]	Wei Z, Yoshihara E, He N, et al. Vitamin D switches BAF complexes to protect β cells[J]. Cell, 2018, 173(5): 1135-1149. doi: 10.1016/j.cell.2018.04.013 URL
[22]	Local A, Huang H, Albuquerque CP, et al. Identification of H3K4me1-associated proteins at mammalian enhancers[J]. Nat Genet, 2018, 50(1): 73-82. doi: 10.1038/s41588-017-0015-6 URL
[23]	Batista TM, Jayavelu AK, Wewer Albrechtsen NJ, et al. A cell-autonomous signature of dysregulated protein phosphorylation underlies muscle insulin resistance in type 2 diabetes[J]. Cell Metab, 2020, 32(5): 844-859. doi: 10.1016/j.cmet.2020.08.007 pmid: 32888406
[24]	Skvortsova K, Iovino N, Bogdanoviéc O. Functions and mechanisms of epigenetic inheritance in animals[J]. Nat Rev Mol Cell Biol, 2018, 19(12): 774-790.
[25]	Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific microRNA regulates insulin secretion[J]. Nature, 2004, 432(7014): 226-230. doi: 10.1038/nature03076 URL
[26]	Al-Muhtaresh HA, Al-Kafaji G. Evaluation of two-diabetes related microRNAs suitability as earlier blood biomarkers for detecting prediabetes and type 2 diabetes mellitus[J]. J Clin Med, 2018, 7(2): 12. doi: 10.3390/jcm7020012 URL
[27]	López-Beas J, Capilla-González V, Aguilera Y, et al. miR-7 modulates hESC differentiation into insulin-producing beta-like cells and contributes to cell maturation[J]. Mol Ther Nucleic Acids, 2018, 12: 463-477. doi: 10.1016/j.omtn.2018.06.002 URL
[28]	Belgardt BF, Ahmed K, Spranger M, et al. The micro-RNA-200 family regulates pancreatic beta cell survival in type 2 diabetes[J]. Nat Med, 2015, 21(6): 619-627. doi: 10.1038/nm.3862 URL
[29]	Huang Q, You W, Li Y, et al. Glucolipotoxicity-inhibited miR-299-5p regulates pancreatic β-cell function and survival[J]. Diabetes, 2018, 67(11): 2280-2292. doi: 10.2337/db18-0223 URL
[30]	Sui M, Chen G, Mao X, et al. Gegen qinlian decoction ameliorates hepatic insulin resistance by silent information regulator1 (SIRT1)-dependent deacetylation of forkhead box O1(FOXO1)[J]. Med Sci Monit, 2019, 25: 8544-8553. doi: 10.12659/MSM.919498 URL
[31]	Long J, Wang Y, Wang W, et al. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy[J]. J Biol Chem, 2011, 286(13): 11837-11848. doi: 10.1074/jbc.M110.194969 URL
[32]	Guo Z, Cao Q, Zhao Z, et al. Biogenesis, features, functions, and disease relationships of a specific circular RNA: CDR1as[J]. Aging Dis, 2020, 11(4): 1009-1020. doi: 10.14336/AD.2019.0920 URL
[33]	Shi R, Chen Y, Liao Y, et al. Research status of differentially expressed noncoding RNAs in type 2 diabetes patients[J]. Biomed Res Int, 2020, 2020: 3816056.
[34]	Akerman I, Tu Z, Beucher A, et al. Human pancreatic β cell lncRNAs control cell-specific regulatory networks[J]. Cell Metab, 2017, 25(2): 400-411. doi: S1550-4131(16)30595-2 pmid: 28041957
[35]	Roundtree IA, Evans ME, Pan T, et al. Dynamic RNA modifications in gene expression regulation[J]. Cell, 2017, 169(7): 1187-1200. doi: S0092-8674(17)30638-4 pmid: 28622506
[36]	Wang Y, Sun J, Lin Z, et al. m6A mRNA methylation controls functional maturation in neonatal murine β-cells[J]. Diabetes, 2020, 69(8): 1708-1722. doi: 10.2337/db19-0906 URL
[37]	Li X, Jiang Y, Sun X, et al. METTL3 is required for maintaining β-cell function[J]. Metabolism, 2021, 116: 154702. doi: 10.1016/j.metabol.2021.154702 URL
[38]	Li Y, Zhang Q, Cui G, et al. m6A regulates liver metabolic disorders and hepatogenous diabetes[J]. Genomics Proteomics Bioinformatics, 2020, 18(4): 371-383. doi: 10.1016/j.gpb.2020.06.003 URL
[39]	Cencioni C, Spallotta F, Greco S, et al. Epigenetic mechanisms of hyperglycemic memory[J]. Int J Biochem Cell Biol, 2014, 51: 155-158. doi: 10.1016/j.biocel.2014.04.014 pmid: 24786298
[40]	Trajkovski M, Hausser J, Soutschek J, et al. MicroRNAs 103 and 107 regulate insulin sensitivity[J]. Nature, 2011, 474(7353): 649-653. doi: 10.1038/nature10112 URL
[41]	Shen W, Tremblay MS, Deshmukh VA, et al. Small-molecule inducer of β cell proliferation identified by high-throughput screening[J]. J Am Chem Soc, 2013, 135(5): 1669-1672. doi: 10.1021/ja309304m URL
[42]	Song MY, Kim EK, Moon WS, et al. Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-κB pathway[J]. Toxicol Appl Pharmacol, 2009, 235(1): 57-67. doi: 10.1016/j.taap.2008.11.007 URL
[43]	Liu X, Liu J, Xiao W, et al. SIRT1 Regulates N6-methyladenosine RNA modification in hepatocarcinogenesis by inducing RANBP2-dependent FTO SUMOylation[J]. Hepatology, 2020, 72(6): 2029-2050. doi: 10.1002/hep.31222 URL

表观遗传修饰：糖尿病防治新靶点

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 1

参考文献 43

相关文章 15

编辑推荐

Metrics

本文评价

[1]	卜凡玉　郭晓峰　徐鹏　王进　薛明宇　潘筱云. 抗生素骨水泥联合其他综合干预措施治疗糖尿病足骨髓炎[J]. 组织工程与重建外科杂志, 2022, 18(4): 328-.
[2]	许晴, 邵慧英, 陈帅, 全进伟, 周清芬, 王敏慧. 延续健康教育和指导对干预2型糖尿病患者冠状动脉斑块进展的影响[J]. 内科理论与实践, 2022, 17(04): 330-333.
[3]	高晶晶, 高艳虹. 早发2型糖尿病流行病学、临床特征及病因机制的研究进展[J]. 内科理论与实践, 2022, 17(04): 344-348.
[4]	孙洪平, 陈国芳, 刘超. 植物性饮食与2型糖尿病的研究进展[J]. 内科理论与实践, 2022, 17(04): 349-352.
[5]	中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下糖尿病管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 136-138.
[6]	陈煦阳, 顾卫琼. 胰岛素自身抗体临床检测应用局限及对策研究进展[J]. 诊断学理论与实践, 2022, 21(01): 95-98.
[7]	张雪，刘晨光. 能否人为控制表观遗传的调控？[J]. 上海交通大学学报, 2021, 55(Sup.1): 32-33.
[8]	王永灵廖明娟李琰蒉纲. 阳和汤加减内服结合负压技术治疗糖尿病足[J]. 组织工程与重建外科杂志, 2021, 17(5): 426-.
[9]	廉洁秦金保祝联. 石墨烯泡沫支架缓释ｎｅｔｒｉｎ－１促进糖尿病大鼠创面愈合的研究 [J]. 组织工程与重建外科杂志, 2021, 17(3): 186-.
[10]	李伟刘涛李霞王巧云白小岗李哲玺. 载绞股蓝皂苷纳米结构脂质载体对ＤＦ大鼠创面愈合及ＥＴ－ＣＧＲＰ平衡的影响[J]. 组织工程与重建外科杂志, 2021, 17(3): 199-.
[11]	王广宇, 杨昕, 张立娟, 谭姣容. 住院新诊断2型糖尿病男性患者血浆总睾酮水平与骨钙素的相关性研究[J]. 诊断学理论与实践, 2021, 20(06): 573-578.
[12]	毕宇芳. 2型糖尿病的全生命周期危险因素研究现状[J]. 内科理论与实践, 2021, 16(06): 373-375.
[13]	孙艳, 代丹娇, 陈智伟, 张华清. 卡格列净对早期糖尿病肾病尿白蛋白/肌酐比值和尿足细胞相关蛋白裂隙素的影响[J]. 内科理论与实践, 2021, 16(06): 387-391.
[14]	高铭, 李娜, 刘煜. 脑-肠轴与2型糖尿病相关性的研究进展[J]. 内科理论与实践, 2021, 16(06): 418-421.
[15]	缪雅, 杨玉琳, 朱怡洁, 盛长生, 田景琰. 糖化血红蛋白变异性与糖尿病微血管并发症关系的研究进展[J]. 内科理论与实践, 2021, 16(06): 427-430.